Patentability of New Form, Use or Property – Section 3(d)
Section 3(d) of the Indian Patents Act limits patentability for new forms or uses of known substances unless enhanced efficacy is proven. The Novartis case illustrates how courts…
18 articles
Section 3(d) of the Indian Patents Act limits patentability for new forms or uses of known substances unless enhanced efficacy is proven. The Novartis case illustrates how courts…
The Supreme Court in Diamond v. Chakrabarty held that human-made microorganisms are patentable under Section 101 of the Patent Act. The case clarified that patent eligibility depends on…
The post examines software patentability in India and the US, focusing on statutory exclusions, recent guidelines, and case law. It discusses current standards and the ongoing evolution of…
This post analyses recent US legal decisions shaping software patent eligibility, focusing on the Alice test and key Federal Circuit rulings. It offers practical insights into how software…
The Enfish v Microsoft judgment signals a positive shift for software patent eligibility under US law. By recognising a specific technical improvement, the Federal Circuit provided clarity on…
This article outlines the key steps and requirements for patent filing in India. It covers eligibility, filing timelines, and necessary documents, providing a clear understanding of the patent…
The Australian High Court has narrowed the eligibility of gene patents, particularly concerning isolated DNA sequences in the BRCA1 case. This analysis explores the legal reasoning, statutory interpretation,…
This post explores how the laws of nature exclusion shapes patent eligibility, especially in biotechnology. It discusses key judicial decisions and the impact of state of the art…